Company intelligence / Profile preview

Simulab

Seattle, Washington, USAsimulab.com ↗

Ownership: Private
Employees: ~27
Development stage: Commercial

Overview

Simulab develops and manufactures realistic medical simulators and task trainers for healthcare education. Their flagship products, such as the TraumaMan System, have become industry standards for surgical training—virtually replacing cadavers in many settings. The company’s latest innovation, SimuSkin™, further enhances the realism of their soft-tissue models. Their solutions are used globally to improve clinical skills, patient safety, and outcomes by providing hands-on practice with high-fidelity anatomical models.

Modalities: Device (medical simulation devices and trainers)Non-pharmacological therapy (training/education tools)Synthetic anatomy models (e.g., soft tissue simulators)
Industry: Therapeutic Medical Devices

Partnerships

Collaborates with leading educators worldwide

Beyond the preview

Go deeper on Simulab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simulab.

Explore the full profile